Buy ORTHOVISC®

ORTHOVISC® is a high molecular weight hyaluronic acid (HA) viscosupplement used for the treatment of knee osteoarthritis. Derived from a non-animal source, its biocompatible formulation mimics the natural synovial fluid found in healthy joints.

Once injected intra-articularly, ORTHOVISC® helps restore the viscoelastic properties of the joint fluid, providing improved lubrication and shock absorption. This reduces friction between joint surfaces, thereby decreasing pain and improving mobility. The HA component also exhibits anti-inflammatory properties, further enhancing joint function over time.

ORTHOVISC® is primarily indicated for:

• The treatment of knee pain in patients with mild to moderate osteoarthritis 
• Supplementing the depleted synovial fluid in the joint 
• Improving functional mobility and reducing dependency on oral pain relievers 
• Providing non-surgical management for individuals who are not candidates for or wish to delay knee replacement surgery 

It is especially recommended for patients who have not responded adequately to conservative treatment methods such as physical therapy or oral NSAIDs.

ORTHOVISC® has been trusted globally for its clinical efficacy and safety profile. It is backed by a robust history of use in orthopedic care and stands out for several reasons:

• Non-animal sourced, ultra-pure sodium hyaluronate 
• High molecular weight for sustained joint residence time 
• Approved for three-injection and single-injection protocols depending on product variant 
• Minimal systemic absorption and low immunogenic potential 
• FDA-approved and CE-marked 

Medical professionals prefer ORTHOVISC® for its consistent performance, ease of integration into orthopedic protocols, and long-standing reputation in joint health therapy.

The effects of ORTHOVISC® may be felt within the first few weeks after injection, with optimal relief occurring between 2 to 4 weeks post-treatment. Clinical studies show that a treatment course—typically one injection per week for three weeks—can provide pain relief lasting up to six months or more, depending on individual patient factors and activity levels.

ORTHOVISC® is generally well tolerated when administered by trained professionals. Its formulation is non-immunogenic and carries minimal risk of adverse events.

Common side effects are typically mild and transient, and may include:

• Localized pain or swelling at the injection site 
• Temporary joint stiffness or warmth 
• Minor bruising 

Adherence to sterile technique and proper joint injection protocols significantly reduces the risk of complications.